Showing results (251-260 of 556) with videos related to
Sort By:
Pageof 56
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 9, 2010
Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patientsMichal Laron, Han Cheng, Bin Zhang, et al.Telemedicine Journal : the Official Journal of the American Telemedicine Association|July 25, 2000
Telemedicine screening of glaucomaH K Li, R A Tang, K Oschner, et al.Survey of Ophthalmology|January 1, 1994
Chiasmal trauma: clinical and imaging considerationsR A Tang, L A Kramer, J Schiffman, et al.Cancer Medicine|November 1, 2018
A real-world, population-based study of patterns of referral, treatment, and outcomes for advanced pancreatic cancerOmar Abdel-Rahman, Yuan Xu, Patricia A Tang, et al.Pharmacotherapy|August 19, 2018
Current and Investigational Agents Targeting the Phosphoinositide 3-Kinase PathwayLaura A Tang, Brianne N Dixon, Kathryn T Maples, et al.Arthritis and Rheumatism|July 19, 2002
Discriminatory sonographic criteria for the diagnosis of carpal tunnel syndromeS M Wong, J F Griffith, A C F Hui, et al.East Asian Archives of Psychiatry : Official Journal of the Hong Kong College of Psychiatrists = Dong Ya Jing Shen Ke Xue Zhi : Xianggang Jing Shen Ke Yi Xue Yuan Qi Kan|August 16, 2011
Psychiatric morbidity at a female residential drug treatment centre in Hong KongA Tang, R Y K Cheung, H J Liang, et al.Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|September 23, 2000
Orbital apex lesion as the presenting manifestation of sarcoidosisE I Segal, R A Tang, A G Lee, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 10, 2009
Assessing visual pathway function in multiple sclerosis patients with multifocal visual evoked potentialsMichal Laron, Han Cheng, Bin Zhang, et al.Genitourinary Medicine|February 1, 1991
The effects of twice and four times daily zidovudine on p24 antigenaemia in CDC stage II/III patientsS Gill, A Tang, M Cordery, et al.Pageof 56